{"entity":{"type":"insider","cik":"0001578771","url":"/insider/0001578771","json_url":"/insider/0001578771.json","name":"Hambleton Julie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":12,"first":"2015-10-30","last":"2025-02-12","span_basis":"filed_date"},"name_variants":[{"name":"Hambleton Julie","source":"filing","n_filings":12,"first_seen":"2015-10-30","last_seen":"2025-02-12"}],"transactions":[{"id":5162048,"accession":"0001104659-25-012362","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-012362","line_url":"/filing/0001104659-25-012362#line-2","is_derivative":false,"issuer_cik":"0001578771","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001578771","owner_cik":"0001578771","owner_name":"Hambleton Julie","owner_display_name":"Hambleton Julie","owner_url":"/insider/0001578771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13774.0,"shares_display":"13,774","price_per_share":53.0134,"price_display":"53.01","price_state":"stated","total_value":730206.5716,"total_display":"730,206.57","total_whole":"730,207","shares_owned_after":4095.0,"shares_owned_after_display":"4,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-12","scope":"insider"},{"id":3237023,"accession":"0001415889-24-020266","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-020266","line_url":"/filing/0001415889-24-020266#line-2","is_derivative":false,"issuer_cik":"0001496323","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001496323","owner_cik":"0001578771","owner_name":"Hambleton Julie","owner_display_name":"Hambleton Julie","owner_url":"/insider/0001578771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15132.0,"shares_display":"15,132","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":211848.0,"total_display":"211,848.00","total_whole":"211,848","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-25","filed_date":"2024-07-29","scope":"insider"},{"id":2656997,"accession":"0001104659-24-068674","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-068674","line_url":"/filing/0001104659-24-068674","is_derivative":false,"issuer_cik":"0001578771","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001578771","owner_cik":"0001578771","owner_name":"Hambleton Julie","owner_display_name":"Hambleton Julie","owner_url":"/insider/0001578771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4648.0,"shares_display":"4,648","price_per_share":40.02753078743546,"price_display":"40.03","price_state":"stated","total_value":186047.9631,"total_display":"186,047.96","total_whole":"186,048","shares_owned_after":5797.0,"shares_owned_after_display":"5,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider","n_lines":4},{"id":8357496,"accession":"0001104659-23-083048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-083048","line_url":"/filing/0001104659-23-083048#line-1","is_derivative":false,"issuer_cik":"0001578771","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001578771","owner_cik":"0001578771","owner_name":"Hambleton Julie","owner_display_name":"Hambleton Julie","owner_url":"/insider/0001578771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2418.0,"shares_display":"2,418","price_per_share":29.3118,"price_display":"29.31","price_state":"stated","total_value":70875.9324,"total_display":"70,875.93","total_whole":"70,876","shares_owned_after":4648.0,"shares_owned_after_display":"4,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-19","filed_date":"2023-07-21","scope":"insider"},{"id":8014719,"accession":"0001104659-23-073743","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-073743","line_url":"/filing/0001104659-23-073743#line-1","is_derivative":false,"issuer_cik":"0001578771","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001578771","owner_cik":"0001578771","owner_name":"Hambleton Julie","owner_display_name":"Hambleton Julie","owner_url":"/insider/0001578771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":26.918,"price_display":"26.92","price_state":"stated","total_value":64603.2,"total_display":"64,603.20","total_whole":"64,603","shares_owned_after":7066.0,"shares_owned_after_display":"7,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-22","scope":"insider"},{"id":8673360,"accession":"0001104659-23-033345","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-033345","line_url":"/filing/0001104659-23-033345#line-1","is_derivative":false,"issuer_cik":"0001578771","issuer_name":"SpringWorks Therapeutics, Inc.","issuer_ticker":"SWTX","issuer_name_source":null,"issuer_url":"/issuer/0001578771","owner_cik":"0001578771","owner_name":"Hambleton Julie","owner_display_name":"Hambleton Julie","owner_url":"/insider/0001578771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1106.0,"shares_display":"1,106","price_per_share":31.5021,"price_display":"31.50","price_state":"stated","total_value":34841.3226,"total_display":"34,841.32","total_whole":"34,841","shares_owned_after":4818.0,"shares_owned_after_display":"4,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-15","filed_date":"2023-03-16","scope":"insider"},{"id":5499147,"accession":"0001209191-21-051011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-051011","line_url":"/filing/0001209191-21-051011#line-1","is_derivative":false,"issuer_cik":"0001496323","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001496323","owner_cik":"0001578771","owner_name":"Hambleton Julie","owner_display_name":"Hambleton Julie","owner_url":"/insider/0001578771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":80000.0,"total_display":"80,000.00","total_whole":"80,000","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-09","filed_date":"2021-08-11","scope":"insider"},{"id":5455403,"accession":"0000899243-21-029053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-029053","line_url":"/filing/0000899243-21-029053#line-1","is_derivative":false,"issuer_cik":"0001578771","issuer_name":"Erasca, Inc.","issuer_ticker":"ERAS","issuer_name_source":null,"issuer_url":"/issuer/0001578771","owner_cik":"0001578771","owner_name":"Hambleton Julie","owner_display_name":"Hambleton Julie","owner_url":"/insider/0001578771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":96000.0,"total_display":"96,000.00","total_whole":"96,000","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-20","filed_date":"2021-07-20","scope":"insider"},{"id":4621782,"accession":"0001209191-21-038002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-038002","line_url":"/filing/0001209191-21-038002#line-1","is_derivative":false,"issuer_cik":"0001496323","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001496323","owner_cik":"0001578771","owner_name":"Hambleton Julie","owner_display_name":"Hambleton Julie","owner_url":"/insider/0001578771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":160000.0,"total_display":"160,000.00","total_whole":"160,000","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-03","scope":"insider"},{"id":7790213,"accession":"0001209191-19-050410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-050410","line_url":"/filing/0001209191-19-050410#line-1","is_derivative":false,"issuer_cik":"0001496323","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001496323","owner_cik":"0001578771","owner_name":"Hambleton Julie","owner_display_name":"Hambleton Julie","owner_url":"/insider/0001578771","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":18.31,"price_display":"18.31","price_state":"stated","total_value":91550.0,"total_display":"91,550.00","total_whole":"91,550","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-18","filed_date":"2019-09-20","scope":"insider"},{"id":8798819,"accession":"0001123292-15-001354","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001123292-15-001354","line_url":"/filing/0001123292-15-001354","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001578771","owner_name":"Hambleton Julie","owner_display_name":"Hambleton Julie","owner_url":"/insider/0001578771","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23108.0,"shares_display":"23,108","price_per_share":34.630328890427556,"price_display":"34.63","price_state":"stated","total_value":800237.64,"total_display":"800,237.64","total_whole":"800,238","shares_owned_after":85919.0,"shares_owned_after_display":"85,919","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-11","filed_date":"2015-11-13","scope":"insider","n_lines":4},{"id":8657351,"accession":"0001123292-15-001273","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001123292-15-001273","line_url":"/filing/0001123292-15-001273#line-4","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001578771","owner_name":"Hambleton Julie","owner_display_name":"Hambleton Julie","owner_url":"/insider/0001578771","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":4300.0,"total_display":"4,300.00","total_whole":"4,300","shares_owned_after":1700.0,"shares_owned_after_display":"1,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-22","filed_date":"2015-10-30","scope":"insider"},{"id":8657347,"accession":"0001123292-15-001273","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001123292-15-001273","line_url":"/filing/0001123292-15-001273#line-3","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001578771","owner_name":"Hambleton Julie","owner_display_name":"Hambleton Julie","owner_url":"/insider/0001578771","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":10.1,"price_display":"10.10","price_state":"stated","total_value":5050.0,"total_display":"5,050.00","total_whole":"5,050","shares_owned_after":1300.0,"shares_owned_after_display":"1,300","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-06","filed_date":"2015-10-30","scope":"insider"},{"id":8657344,"accession":"0001123292-15-001273","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001123292-15-001273","line_url":"/filing/0001123292-15-001273#line-2","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001578771","owner_name":"Hambleton Julie","owner_display_name":"Hambleton Julie","owner_url":"/insider/0001578771","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":64.0,"shares_display":"64","price_per_share":13.7,"price_display":"13.70","price_state":"stated","total_value":876.8,"total_display":"876.80","total_whole":"877","shares_owned_after":64.0,"shares_owned_after_display":"64","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-30","filed_date":"2015-10-30","scope":"insider"},{"id":8657340,"accession":"0001123292-15-001273","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-15-001273","line_url":"/filing/0001123292-15-001273#line-1","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001578771","owner_name":"Hambleton Julie","owner_display_name":"Hambleton Julie","owner_url":"/insider/0001578771","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":14.75,"price_display":"14.75","price_state":"stated","total_value":11800.0,"total_display":"11,800.00","total_whole":"11,800","shares_owned_after":800.0,"shares_owned_after_display":"800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-18","filed_date":"2015-10-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001773427","name":"SpringWorks Therapeutics, Inc.","url":"/issuer/0001773427","role":"Director","n_filings":5,"first_seen":"2023-03-16","last_seen":"2025-02-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001496323","name":"IGM Biosciences, Inc.","url":"/issuer/0001496323","role":"Director","n_filings":4,"first_seen":"2019-09-20","last_seen":"2024-07-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001761918","name":"Erasca, Inc.","url":"/issuer/0001761918","role":"Director","n_filings":1,"first_seen":"2021-07-20","last_seen":"2021-07-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001175505","name":"FIVE PRIME THERAPEUTICS INC","url":"/issuer/0001175505","role":"Officer (EVP & Chief Medical Officer)","n_filings":2,"first_seen":"2015-10-30","last_seen":"2015-11-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001578771","retrieved_at":"2026-08-27T09:36:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}